ST6GAL1 and Familial prostate cancer: In addition to promoting osteoclasts in the pre-metastatic niche, our data also suggests that ST6GAL1 enhances the development of M2 like macrophages and can also regulate sialoglycans on prostate cancer cells that engage Siglec receptors.